BACKGROUND: Animal models are essential for analyzing the allergenic potential of food proteins and for investigating mechanisms underlying food allergy. Based on previous studies revealing acid-suppression medication as risk factor for food allergy induction, we aimed to establish a mouse model mimicking the natural route of sensitization in patients. METHODS: The effect of acid-suppressing medication on murine gastric pH was assessed by intragastric pH measurements after two injections of a proton pump inhibitor (PPI). To investigate dose-dependency, mice were fed different concentrations of ovalbumin (OVA; 0.2, 0.5, 1.0, 2.5 or 5.0mg) either with or without anti-ulcer medication. Additionally, different routes of exposure (i.p. vs. oral) were compared in a second immunization experiment. Sera were screened for OVA-specific antibody titers (IgG1, IgG2a and IgE) in ELISA and RBL assay. Clinical reactivity was evaluated by measuring rectal temperature after oral challenge and by type I skin tests. RESULTS: Two intravenous injections of PPI significantly elevated the gastric pH from 2.97 to 5.3. Only oral immunization with 0.2mg OVA under anti-acid medication rendered elevated IgG1, IgG2a and IgE titers compared to all other concentrations. Protein feeding alone altered antibody titers only marginally. Even though also i.p. immunizations induced high levels of specific IgE, only oral immunizations under anti-acids induced anaphylactic reactions evidenced by a significant decrease of body temperature. CONCLUSION: Only low-dosage ovalbumin feedings under anti-acid medication resulted in IgE mediated food allergy. Based on this knowledge we have established a suitable food allergy model for further investigations of food adverse reactions.
BACKGROUND: Animal models are essential for analyzing the allergenic potential of food proteins and for investigating mechanisms underlying food allergy. Based on previous studies revealing acid-suppression medication as risk factor for food allergy induction, we aimed to establish a mouse model mimicking the natural route of sensitization in patients. METHODS: The effect of acid-suppressing medication on murine gastric pH was assessed by intragastric pH measurements after two injections of a proton pump inhibitor (PPI). To investigate dose-dependency, mice were fed different concentrations of ovalbumin (OVA; 0.2, 0.5, 1.0, 2.5 or 5.0mg) either with or without anti-ulcer medication. Additionally, different routes of exposure (i.p. vs. oral) were compared in a second immunization experiment. Sera were screened for OVA-specific antibody titers (IgG1, IgG2a and IgE) in ELISA and RBL assay. Clinical reactivity was evaluated by measuring rectal temperature after oral challenge and by type I skin tests. RESULTS: Two intravenous injections of PPI significantly elevated the gastric pH from 2.97 to 5.3. Only oral immunization with 0.2mg OVA under anti-acid medication rendered elevated IgG1, IgG2a and IgE titers compared to all other concentrations. Protein feeding alone altered antibody titers only marginally. Even though also i.p. immunizations induced high levels of specific IgE, only oral immunizations under anti-acids induced anaphylactic reactions evidenced by a significant decrease of body temperature. CONCLUSION: Only low-dosage ovalbumin feedings under anti-acid medication resulted in IgE mediated food allergy. Based on this knowledge we have established a suitable food allergy model for further investigations of food adverse reactions.
Authors: Fred D Finkelman; Marc E Rothenberg; Eric B Brandt; Suzanne C Morris; Richard T Strait Journal: J Allergy Clin Immunol Date: 2005-03 Impact factor: 10.793
Authors: J C S Saldanha; D L Gargiulo; S S Silva; F H Carmo-Pinto; M C Andrade; J I Alvarez-Leite; M M Teixeira; D C Cara Journal: Braz J Med Biol Res Date: 2004-05-27 Impact factor: 2.590
Authors: R Brunner; J Wallmann; K Szalai; P Karagiannis; T Kopp; O Scheiner; E Jensen-Jarolim; I Pali-Schöll Journal: Clin Exp Allergy Date: 2007-09-10 Impact factor: 5.018
Authors: David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German Journal: Crit Rev Food Sci Nutr Date: 2017-10-13 Impact factor: 11.176
Authors: Eva Untersmayr; Susanne C Diesner; Gertie Janneke Oostingh; Kathrin Selzle; Tobias Pfaller; Cornelia Schultz; Yingyi Zhang; Durga Krishnamurthy; Philipp Starkl; Regina Knittelfelder; Elisabeth Förster-Waldl; Arnold Pollak; Otto Scheiner; Ulrich Pöschl; Erika Jensen-Jarolim; Albert Duschl Journal: PLoS One Date: 2010-12-02 Impact factor: 3.240
Authors: Lisa M Bartnikas; Michael F Gurish; Oliver T Burton; Sabine Leisten; Erin Janssen; Hans C Oettgen; Jacqueline Beaupré; Christopher N Lewis; K Frank Austen; Stephanie Schulte; Jason L Hornick; Raif S Geha; Michiko K Oyoshi Journal: J Allergy Clin Immunol Date: 2013-02 Impact factor: 10.793
Authors: A B Riemer; S Gruber; I Pali-Schöll; T Kinaciyan; E Untersmayr; E Jensen-Jarolim Journal: Clin Exp Allergy Date: 2009-10-07 Impact factor: 5.018
Authors: Susanne C Diesner; Ana Olivera; Sandra Dillahunt; Cornelia Schultz; Thomas Watzlawek; Elisabeth Förster-Waldl; Arnold Pollak; Erika Jensen-Jarolim; Eva Untersmayr; Juan Rivera Journal: Immunol Lett Date: 2011-10-14 Impact factor: 3.685